InsidersTradesSigma
Follow the JOINN Laboratories (China) Co., Ltd. stock price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares are listed on the HK market, under the authority of HKEX. Operating in the Health Care sector, JOINN Laboratories (China) Co., Ltd. has logged 6 reports. Market capitalisation: €18.3bn. The latest transaction was disclosed on 7 May 2026 (Purchase). Among the most active insiders: Feng Yuxia. All data is free.
6
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate JOINN Laboratories (China) Co., Ltd. Buy (bullish), based on 5 analysts. Average price target: HK$22.74.
4Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,720 of 28,932 companies
47.5
score / 100
Value32
Quality63
FCF yld1.6%
Earn yld1.6%
EV/EBITDA38.2x
ROE5.9%
Gross mgn21%
Net mgn18%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 May 2026
Declarations6 total
500,000 sharesShareXHKGHKEX:DA20260506E00389
80,000 sharesShareXHKGHKEX:DA20260506E00397
60,000 sharesShareXHKGHKEX:DA20260506E00402
60,000 sharesShareXHKGHKEX:DA20260506E00430
6 of 6 declarations
About JOINN Laboratories (China) Co., Ltd.
JOINN Laboratories (China) Co., Ltd. is a company focused on drug research and development, as well as preclinical and clinical testing services. It is listed on the Hong Kong Stock Exchange.